DNA Sequencing Market Size, Share, and Trends 2024 to 2034

DNA Sequencing Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Sequencing Market 

5.1. COVID-19 Landscape: DNA Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product, 2024-2034

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Services

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology, 2024-2034

9.1.1. Third Generation DNA Sequencing

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Next-Generation Sequencing

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Sanger Sequencing

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global DNA Sequencing Market, By Application 

10.1. DNA Sequencing Market, by Application, 2024-2034

10.1.1. Clinical Investigation

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Oncology

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Forensics & Agrigenomics

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Reproductive Health

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. HLA Typing

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global DNA Sequencing Market, By End-Use 

11.1. DNA Sequencing Market, by End-Use, 2024-2034

11.1.1. Clinical Research

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Academic Research

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Biotechnology & Pharmaceutical Companies

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Hospitals & Clinics

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

Chapter 13. Company Profiles

13.1. Agilent Technologies

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Illumina, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. QIAGEN

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Perkin Elmer

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Thermo Fisher Scientific

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Hoffmann-La Roche Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Macrogen, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bio-Rad Laboratories, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Oxford Nanopore Technologies Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Myriad Genetics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms